Investigation of SR-BI gene rs4238001 and rs5888 polymorphisms prevalence and effects on Turkish patients with metabolic syndrome Metabolik sendromlu Türk hastalarında SR-BI geni rs4238001 ve rs5888 polimorfizmlerinin prevalansı ve etkilerinin araştırılması


Filizfidan M., Pence S., Çaykara B., ALSAADONI H., Marakoğlu K., PENÇE H. H., ...Daha Fazla

Turkish Journal of Biochemistry, cilt.45, sa.4, ss.435-441, 2019 (SCI-Expanded, Scopus, TRDizin)

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 45 Sayı: 4
  • Basım Tarihi: 2019
  • Doi Numarası: 10.1515/tjb-2018-0499
  • Dergi Adı: Turkish Journal of Biochemistry
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.435-441
  • Anahtar Kelimeler: Metabolic syndrome, SR-BI, rs5888, rs4238001, Polymorphism
  • Sağlık Bilimleri Üniversitesi Adresli: Evet

Özet

Aim: Metabolic syndrome (MS) is associated with dyslipidemia such as hypertriglyceridemia and high-density lipoprotein (HDL) levels. Scavenger receptor BI (SR-BI) is the transmembrane receptor that regulates selective intake of cholesterol esters by the liver and it binds to HDL with high affinity. This study was aimed to determine the effects of SR-BI gen variations upon proatherogenic and antiatherogenic lipid profiles in the patients with metabolic syndrome. Methods: The patient group was consisted of 104 (30–65 years) male subjects who were diagnosed with MS and 100 healthy male subjects were included in control group. DNA was isolated from blood samples. SR-BI gene rs4238001 and rs5888 variants were examined by SNaPshot multiplexing system. SPSS 18 was used for statistical analysis and p < 0.05 considered as statistically significant. Results: It was found that SR-BI gene rs4238001 T allele increased the risk of metabolic syndrome 1.61 fold (p = 0.02). Subjects with TT genotype 2.847 fold increased the risk of metabolic syndrome according to subjects with CC genotype (p = 0.017). Conclusions: SR-BI rs4238001 variation may be related to an increased risk of metabolic syndrome.